News
Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...
Pharmaceutical giant Eli Lilly alleges the companies are selling off-brand versions of its best-selling diabetes and ...
Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...
The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve ...
11h
WISH-TV on MSNEli Lilly spearheads global initiative to protect wildlife using synthetic alternativesEli Lilly and Company is leading a global effort to protect wildlife by shifting away from horseshoe crab blood and using a ...
Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...
1don MSN
We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...
18h
Barchart on MSNEli Lilly's Quarterly Earnings Preview: What You Need to KnowWith a market cap of $775.6 billion, Eli Lilly and Company (LLY) is a global biopharmaceutical leader with leading products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results